Recent research ties neurological diseases to the coronavirus 2019 (COVID-19) pandemic, a condition that has disrupted our lives and made our planet a different one from December 2019 to today. It is a unique kind of human coronavirus that has been identified as the causative agent of SARS-CoV-2 and has been reported for the first time in Wuhan, China. COVID-19 infection, according to new research, can aggravate the clinical spectrum of exhibited neurological illnesses. Recent studies, on the other hand, have brought the possible significance of this novel coronavirus in the future development of neurological diseases into the forefront, making the neurobiological relationship between these two conditions even more intriguing. Confinement, which may lead to social isolation, is one of the social consequences of the Covid-19's impact on neurodegenerative disorders.
Important Alert:
X
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Electrophysiology and alzheimer's pathology: A scoping review on eeg correlations with CSF biomarkers
Charikleia Karastamati, University of Pavia, Italy
Title : The vital role of care homes in supporting individuals with neurological conditions
Akankunda Veronicah, Golden Age Elderly Homes Kampala, Uganda
Title : Semantic-based memory-encoding strategy in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised
Karen P Y Liu, Western Sydney University, Hong Kong